Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 7.7% in the afternoon session after it commenced a cash tender offer to buy back up to $75.74 million of its outstanding senior...

Why Fortrea (FTRE) Stock Is Trading Up Today

October 20, 2025

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt

October 20, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Where Fortrea Holdings Stands With Analysts ↗

October 02, 2025

Via Benzinga

3 Unpopular Stocks That Concern Us

October 20, 2025

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

October 15, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

3 Volatile Stocks Walking a Fine Line

October 15, 2025

Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

October 11, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 6.1% in the afternoon session after Evercore ISI Group raised its price target on the company to $11.00 from a previous $7.00.

Topics Economy Government World Trade

Why Fortrea (FTRE) Stock Is Up Today

October 08, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 6.3% in the afternoon session after negative news weighed on the broader healthcare sector, including a new U.S. government...

Topics Artificial Intelligence Initial Public Offering World Trade

Why Fortrea (FTRE) Shares Are Sliding Today

September 25, 2025

Topics Artificial Intelligence Initial Public Offering World Trade

Fortrea Appoints William Sharbaugh to Board of Directors

September 22, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

3 Small-Cap Stocks We Find Risky

September 11, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.5% in the afternoon session after Baird raised its price target on the stock to $14.00. This positive analyst action adds to...

Why Fortrea (FTRE) Stock Is Trading Up Today

September 03, 2025

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as...

Topics Artificial Intelligence Economy Initial Public Offering

Demystifying Fortrea Holdings: Insights From 6 Analyst Reviews ↗

September 03, 2025

Via Benzinga

3 Stocks Under $10 We Find Risky

September 02, 2025

Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks

August 24, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,...

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Topics Economy

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

August 22, 2025

Reflecting On Drug Development Inputs & Services Stocks’ Q2 Earnings: Fortrea (NASDAQ:FTRE)

Topics Economy

August 21, 2025

Looking back on drug development inputs & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Fortrea (NASDAQ:FTRE) and its peers.

LGI Homes, Moderna, Fortrea, 10x Genomics, and Cogent Shares Are Falling, What You Need To Know

August 21, 2025

A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S....

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

Topics Economy Stocks

3 Cash-Burning Stocks We’re Skeptical Of

August 18, 2025

Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six...

Topics Artificial Intelligence Economy

1 Healthcare Stock to Own for Decades and 2 That Underwhelm

August 13, 2025

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know

Topics Stocks

August 12, 2025

A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index...

FTRE Q2 Deep Dive: Revenue Growth Driven by Clinical Pharmacology and Operational Restructuring

Topics Bonds Economy Stocks

August 12, 2025

Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.2% year on year to $710.3 million. The company’s full-year...

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

1 Russell 2000 Stock with Solid Fundamentals and 2 We Find Risky

August 07, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 4.4% in the afternoon session after the company reported mixed second-quarter financial results, where a massive net loss...

Fortrea (FTRE) Q2 Revenue Jumps 7% ↗

August 06, 2025

Via The Motley Fool

Topics Artificial Intelligence

Why Fortrea (FTRE) Shares Are Sliding Today

August 06, 2025

Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.2% year on year to $710.3 million. The company’s...

Fortrea (NASDAQ:FTRE) Reports Bullish Q2, Stock Soars

August 06, 2025